Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of Montelukast on Early Life Wheezing

Trial Profile

Effects of Montelukast on Early Life Wheezing

Phase of Trial: Phase II/III

Latest Information Update: 01 Feb 2018

At a glance

  • Drugs Montelukast (Primary)
  • Indications Wheezing
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Dec 2016 Status changed from active, no longer recruiting to completed.
    • 02 Nov 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 20 Feb 2013 Planned end date changed from 1 Jun 2009 to 1 Sep 2020 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top